A Multicenter, Randomized, Parallel-group, Double-blind, Two-arm, Phase III Study to Evaluate the Safety and Efficacy of Anifrolumab Compared with Placebo in Male and Female Participants 18 to 70 years of Age inclusive with Systemic Sclerosis

14661D3460C00002OpenA Multicenter, Randomized, Parallel-group, Double-blind, Two-arm, Phase III Study to Evaluate the Safety and Efficacy of Anifrolumab Compared with Placebo in Male and Female Participants 18 to 70 years of Age inclusive with Systemic SclerosisNCT05925803IndustrialAdultTreatmentIIIDiseases Of The Musculoskeletal System And Connective TissueSteen, VirginiaGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterGUMC Medicine Rheumatology; GUMC PFS2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>